Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretome-MSCs in Severe COVID-19
NCT04753476Phase 2Unknown
- Sponsor
- Stem Cell and Cancer Research Indonesia
- Start
- Jun 2020
- Primary completion
- Feb 2022
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of Hypoxia-Mesenchymal Stem Cell Secretome in coronavirus disease 2019 (COVID-19), sponsored by Stem Cell and Cancer Research Indonesia. Status: unknown.
02
Drugs
Hypoxia-Mesenchymal Stem Cell Secretome
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04753476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04753476.